Trials in Long Beach, California
Here are the top 10 medical studies for alzheimer's disease in Long Beach, California
Popular Filters
Phase 3 Trials
Behavioural Intervention
Masupirdine for Agitation in Alzheimer's Disease
Recruiting1 awardPhase 3
Anaheim, California
This trial will test a medication called masupirdine, which participants will take regularly. It targets people with Alzheimer's disease who are experiencing agitation. The study aims to see if masupirdine can help reduce agitation and ensure it is safe and well-tolerated. Masupirdine has been previously evaluated in patients with moderate Alzheimer's disease and was found to be generally safe and well-tolerated.
Monoclonal Antibodies
Aducanumab for Alzheimer's Disease
Recruiting1 awardPhase 3
Newport Beach, California
This trial is testing whether a drug called aducanumab can slow down cognitive and functional decline in people with early Alzheimer's disease, as measured by the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score.
Monoclonal Antibodies
Investigational Alzheimer's Drugs for Early Onset Alzheimer's Disease
Recruiting0 awardsPhase 2 & 3
Los Angeles, California
This trial tests two drugs, lecanemab and E2814, in people with a genetic mutation that causes Alzheimer's disease. Lecanemab helps remove harmful protein clumps from the brain, while E2814 prevents harmful protein tangles from forming. The goal is to see if these drugs can slow down or improve symptoms of Alzheimer's.
Melatonin Receptor Agonist
Piromelatine for Alzheimer's Disease
Recruiting0 awardsPhase 2 & 3
Long Beach, California
This trial tests piromelatine, a pill taken before bed, in people with mild Alzheimer's who lack a specific genetic variation. The goal is to see if it can improve brain function and slow down dementia progression.
NMDA receptor antagonist
AXS-05 for Alzheimer's Disease Agitation
Recruiting1 awardPhase 3
Long Beach, California
This trial is testing a new medication called AXS-05 to see if it can help reduce agitation in people with Alzheimer's disease. The goal is to find out if AXS-05 can balance brain chemicals to calm agitation and improve behavior. AXS-05, a combination of dextromethorphan and bupropion, is being investigated for its potential to treat agitation in Alzheimer's disease and has shown promise in early clinical trials.
Trials With No Placebo
Monoclonal Antibodies
TB006 for Alzheimer's Disease
Recruiting1 awardPhase 2
San Diego, California
This trial is testing TB006, a treatment for Alzheimer's disease. It includes people who were part of a previous study or were eligible for it. Researchers want to see how safe TB006 is, how it moves through the body, and its effects on Alzheimer's symptoms over time. T-006, a small-molecule compound derived from tetramethylpyrazine (TMP), has potential for the treatment of neurological diseases.
Behavioral Intervention
Music-Based Interventions for Alzheimer's Disease
Recruiting1 award
Los Angeles, California
This trial will study how participating in choir training and engaging with music can improve hearing, communication, and overall well-being in older adults, especially those at risk of dementia.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.